Deguelin action involves c-Met and EGFR signaling pathways in triple negative breast cancer cells.
<h4>Background</h4>Treatment of breast cancer patients with antiestrogens and aromatase inhibitor(s) or Herceptin have shown significant success in steroid receptor positive or Her-2+ breast cancers respectively. However, choice of treatments for breast cancer patients with negative stat...
Enregistré dans:
Auteurs principaux: | , , , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/39d2c5de925e46dda68a3b55ca44f64b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|